Lung Cancer FDA Approved Drugs
This page offers you an assortment of all the lung cancer drugs which are approved by Food and Drug Administration (FDA). This compilation is helpful in determining the common drug combinations that are used in the treatment of lung cancer. Mostly, the individual drugs in the combinations are FDA approved and the combinations themselves may not be approved. The treatment options are mainly based on the stage of cancer and the overall health of the patient. Doctors use various lung cancer drug combinations as a part of the treatment. Though we have tried to include most of the FDA approved drugs for lung cancer but there may be some other drugs as well which are not listed here. DRUGS APPROVED FOR NON-SMALL CELL LUNG CANCER Abitrexate (Methotrexate); Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation); Afatinib Dimaleate; Afinitor (Everolimus); Alecensa (Alectinib); Alectinib; Alimta (Pemetrexed Disodium); Atezolizumab; Avastin (Bevacizumab); Bevacizumab; Carboplatin;